Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeNon-Current DebtOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Cash from Investing Activities: 2019-2025

Historic Cash from Investing Activities for Legend Biotech (LEGN) over the last 7 years, with Sep 2025 value amounting to -$20.0 million.

  • Legend Biotech's Cash from Investing Activities fell 106.08% to -$20.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$16.7 million, marking a year-over-year increase of 95.29%. This contributed to the annual value of -$850.5 million for FY2024, which is 1016.67% down from last year.
  • Per Legend Biotech's latest filing, its Cash from Investing Activities stood at -$20.0 million for Q3 2025, which was up 87.92% from -$165.5 million recorded in Q2 2025.
  • In the past 5 years, Legend Biotech's Cash from Investing Activities registered a high of $407.5 million during Q4 2023, and its lowest value of -$695.6 million during Q2 2024.
  • Moreover, its 3-year median value for Cash from Investing Activities was -$87.8 million (2024), whereas its average is -$62.4 million.
  • Within the past 5 years, the most significant YoY rise in Legend Biotech's Cash from Investing Activities was 1,534.48% (2023), while the steepest drop was 4,807.27% (2023).
  • Quarterly analysis of 5 years shows Legend Biotech's Cash from Investing Activities stood at $96.5 million in 2021, then slumped by 74.17% to $24.9 million in 2022, then spiked by 1,534.48% to $407.5 million in 2023, then slumped by 121.56% to -$87.8 million in 2024, then crashed by 106.08% to -$20.0 million in 2025.
  • Its Cash from Investing Activities stands at -$20.0 million for Q3 2025, versus -$165.5 million for Q2 2025 and $256.6 million for Q1 2025.